search
Back to results

Transfusion Strategies in Pediatric Cardiothoracic Surgery

Primary Purpose

Congenital Heart Disease

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
transfusion strategy
Low Hb transfusion group
Sponsored by
University of Rochester
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Congenital Heart Disease focused on measuring Single ventricle, Bidirectional Glenn, Fontan, Congenital cardiac disease, Red blood cell transfusion, oxygen utilization, lactate level, hemoglobin level

Eligibility Criteria

4 Months - 7 Years (Child)All SexesDoes not accept healthy volunteers

Inclusion Criteria: 4 months to 6.99 years of age surgical candidates for cavopulmonary connection English speaking Exclusion Criteria: presence of known bleeding disorder presence of known coagulopathy age < 4 months age > 7 years non-English speaking

Sites / Locations

  • University of Rochester

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

1

2

Arm Description

High Hemoglobin group; goal Hb >13g/dl. 10cc/kg RBCs are transfused for any hemoglobin value under 13g/dl regardless whether clinical indication for transfusion exists.

Low Hb transfusion group; goal to not transfuse unless the Hb <9.0 g/dl. 10cc/kg RBCs are transfused only if the Hemoglobin is under 9.0g/dl and clinical indications for transfusion exist.

Outcomes

Primary Outcome Measures

Mean Arterial Lactate Level
Mean arterial lactate for the first 48 hours post-op.
Peak Arterial Lactate Level
Peak arterial lactate level for the 48 hour post-op study period.

Secondary Outcome Measures

Oxygen Utilization During the 8 Hour to 72 Hours Post-operative Period.
Length of Mechanical Ventilation
Length of Oxygen Use
Length of Vasoactive Agent Administration
Volume of Blood Transfused
Mortality Before Hospital Discharge

Full Information

First Posted
July 5, 2006
Last Updated
May 29, 2015
Sponsor
University of Rochester
search

1. Study Identification

Unique Protocol Identification Number
NCT00350220
Brief Title
Transfusion Strategies in Pediatric Cardiothoracic Surgery
Official Title
A Prospective, Randomized, Controlled Clinical Trial Comparing Two Transfusion Strategies in Pediatric Patients Undergoing Cavopulmonary Connection.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2015
Overall Recruitment Status
Completed
Study Start Date
July 2006 (undefined)
Primary Completion Date
September 2009 (Actual)
Study Completion Date
September 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Rochester

4. Oversight

5. Study Description

Brief Summary
The purpose of this study is to determine the best red blood cell(hemoglobin) level for infants and children following surgical repair of particular heart defects. These children often receive red blood cell transfusions after surgery, but what the best hemoglobin level is for them remains unknown.
Detailed Description
Objective: To compare mean post-operative arterial lactate levels, oxygen utilization, and outcome measures in pediatric patients undergoing cavopulmonary connection managed with two different red blood cell transfusion strategies. Methods: We propose a prospective, randomized clinical trial of sixty-six pediatric patients with cyanotic, complex congenital cardiac disease undergoing cavopulmonary connection as their operative repair. Thirty-three patients will be randomly assigned to a low Hb strategy of transfusion, in which red cells are transfused if the hemoglobin concentration falls below 9.0 g/dL, and hemoglobin concentrations are maintained about 8.5 g/dL. Thirty-three additional patients will be randomly assigned to the high Hb transfusion strategy, where red cells are transfused if the hemoglobin concentration falls below 13.0 g/dL, and hemoglobin concentrations are maintained about 12.5 g/dL. The primary endpoint will be comparison of mean arterial lactate levels from 8 to 72 hours post-operatively. The secondary endpoints will be oxygen utilization reflected by the arterio-venous oxygen difference (AV-difference) and arterio-cerebral oxygen difference (AC-difference). Measures of oxygen utilization will be derived from arterial oxygen saturation (SaO2), mixed venous oxygen saturation (SvO2), and cerebral oxygen saturation (ScO2) collected at various time points throughout the study. Tertiary outcome measures will be length of mechanical ventilation, length of oxygen use and of vasoactive agent administration, length pediatric cardiac intensive care unit (PCICU) admission, volume of blood transfused, and mortality. Data from each group will be compared using analysis of variance to assess for the presence of a difference between the two transfusion strategies. If a significant difference between the two groups exists, T-tests will be performed to compare data points between each group to assess for a significant difference. Hypothesis: A more restrictive (low Hb) strategy of red cell transfusion will be as effective as, and possibly superior to, the historical (high Hb) approach. Allowing a lower Hb concentration will decrease RBC donor exposure and may decrease the known complications of RBC transfusions. We postulate that no significant difference will exist between the two transfusion groups in regards to hemodynamic and cardiopulmonary status (as evidenced by mean lactate levels) and oxygen utilization.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Congenital Heart Disease
Keywords
Single ventricle, Bidirectional Glenn, Fontan, Congenital cardiac disease, Red blood cell transfusion, oxygen utilization, lactate level, hemoglobin level

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Active Comparator
Arm Description
High Hemoglobin group; goal Hb >13g/dl. 10cc/kg RBCs are transfused for any hemoglobin value under 13g/dl regardless whether clinical indication for transfusion exists.
Arm Title
2
Arm Type
Active Comparator
Arm Description
Low Hb transfusion group; goal to not transfuse unless the Hb <9.0 g/dl. 10cc/kg RBCs are transfused only if the Hemoglobin is under 9.0g/dl and clinical indications for transfusion exist.
Intervention Type
Other
Intervention Name(s)
transfusion strategy
Intervention Description
For the High Hb group; transfusions will be given to keep the Hb >13.0 g/dl
Intervention Type
Other
Intervention Name(s)
Low Hb transfusion group
Intervention Description
RBCs will not be transfused unless the Hb < 9.0 g/dl
Primary Outcome Measure Information:
Title
Mean Arterial Lactate Level
Description
Mean arterial lactate for the first 48 hours post-op.
Time Frame
48 hours
Title
Peak Arterial Lactate Level
Description
Peak arterial lactate level for the 48 hour post-op study period.
Time Frame
48 hours
Secondary Outcome Measure Information:
Title
Oxygen Utilization During the 8 Hour to 72 Hours Post-operative Period.
Time Frame
3 days
Title
Length of Mechanical Ventilation
Time Frame
3 days
Title
Length of Oxygen Use
Time Frame
3 days
Title
Length of Vasoactive Agent Administration
Time Frame
3 days
Title
Volume of Blood Transfused
Time Frame
3 days
Title
Mortality Before Hospital Discharge
Time Frame
30 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
4 Months
Maximum Age & Unit of Time
7 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 4 months to 6.99 years of age surgical candidates for cavopulmonary connection English speaking Exclusion Criteria: presence of known bleeding disorder presence of known coagulopathy age < 4 months age > 7 years non-English speaking
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jill M Cholette, MD
Organizational Affiliation
University of Rochester
Official's Role
Principal Investigator
Facility Information:
Facility Name
University of Rochester
City
Rochester
State/Province
New York
ZIP/Postal Code
14642
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Transfusion Strategies in Pediatric Cardiothoracic Surgery

We'll reach out to this number within 24 hrs